Why India’s medicines need integrated authentication, enforceable standards
Triggered by recent high profile operations involving counterfeit semaglutide in the domestic markets and anti-rabies vaccines…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Interviews
Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions
Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for building a future-ready organisation powered by…
Traceability pays back in many ways
S Swaminathan, CEO, GS1 India explains to Express Pharma the broader benefits of the expanded QR code mandate, and how…
Future of MP Pharma lies in quality manufacturing, exports and contract development
Madhya Pradesh is steadily emerging as a pharma manufacturing hub. How do you assess the current growth trajectory of the state's…
Why India’s biopharma value shift could unlock an additional $125-bn opportunity
What are the broad global consumer health trends driving the global biopharma sector this decade?
We believe that global…
India has emerged as a strategically important hub for Merck
Since its expansion, how has the Peenya facility contributed to strengthening Merck's manufacturing footprint in the Asia-Pacific…
India is one of Zoetis’ strongest markets in Asia for in-ovo vaccination
The recent H5N1 avian influenza resurgence in poultry farms in certain districts of Maharashtra and Karnataka once again reminds…
We’re building for global markets, not just domestic scale
As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is steering the 60-year-old pharmaceutical company…
Future will belong to collaborative and implementation-focused ecosystems
As India’s pharma cold chain industry evolves to support biologics, vaccines and other temperature-sensitive therapies, the focus…
The regulatory landscape in India is becoming more structured and globally aligned
Raay Neo Pharma has officially unveiled its operations with the aim to contribute to quality healthcare for all Indians. The…
India is well on its path to strongly push back the perception battle of quality
As we mark International Clinical Trial Day today, Dr Seema Pai, President, ISCR explains to Viveka Roychowdhury why it is…
Even drug-resistant cancer targets can be tackled with the right design strategy
Your work leverages AI and machine learning to optimise CAR-T cell therapy. How does this approach fundamentally differ from…
A uniform pricing regime ignores the heterogeneity within the pharma sector
Dr Amit Kumar: How can policy frameworks better align commercial interests in the pharma sector with broader public health goals?…
India brings together a rare and powerful combination of capabilities
Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction with Kalyani Sharma, discusses the strategic…
Mumbai Experience Center reflects Agilent’s continued commitment to India
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…
Industrial and infrastructure sectors are undergoing rapid modernisation
How critical is infrastructure automation in pharma facilities?
Infrastructure is integral to maintaining controlled…
Companies need to look at anti-counterfeiting solutions from the perspective of protecting revenue,…
Can you briefly explain ASPA’s evolution and how the anti‑counterfeiting ecosystem has changed?
ASPA as an organisation started…
What truly differentiates Transchem is our technical-first approach
What are Transchem's core focus areas today, and which segments are driving your growth?
Transchem’s core focus today is on…
Targeted incentives for innovation-driven research would further strengthen India’s biotech…
What unmet need are you fundamentally solving?
Vyome is focused on areas of significant unmet medical need within…
In 2026, India serves as the reliable ‘technical engine’ for global research
How would you describe the current and evolving clinical research landscape in India, and what key shifts are shaping its future?…